Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder.
Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, Schumacher K, Bramlet M, Welsh DE, Bauer MS. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials. 2012 Jul; 33(4):666-78.